SensArs
  • Home
  • Technology
    • Concept and Product
    • Publications
  • About us
    • Company
    • Our Team
    • Projects
  • News
    • News
    • Media Appearances
  • Contact

Projects

SensAgain

GoSafe

BCI-FOR-PAIN

NeuHeart

Search

Recent posts

  • SensArs has been granted FDA Breakthrough Device Designation for SENSY September 6, 2021
  • SensArs has been awarded with a DIH-HERO Technology Transfer Experiment Grant for treating chronic neuropathic pain May 20, 2021
  • Our CEO, Francesco Petrini, was nominated among the 35 innovators under 35, from MIT July 9, 2020
  • SensArs coordinates a consortium of 4 partners coming from 4 countries to take to market its product SENSY October 4, 2019
  • SensArs financed from the European Commission to explore the feasibility of stimulating the vagal nerve January 1, 2019
Rue du Maupas 38, 1004,
Lausanne
office@sensars.com francesco.petrini@sensars.com
+41779024490
© 2021 SensArs
Powered by Tag-Labs